FABP3 and peripheral arterial disease: For instance, while FABP3 is an effective biomarker of cardiac injury, our recent work on patients with peripheral artery disease (PAD) and critical limb ischemia, which are common complication of atherosclerosis, showed elevated blood FABP3 in association with PAD’s severity in the absence of any signs of myocardial ischemia.